rofecoxib has been researched along with Retinopathy of Prematurity in 1 studies
Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilkinson-Berka, JL | 1 |
| Alousis, NS | 1 |
| Kelly, DJ | 1 |
| Gilbert, RE | 1 |
1 other study available for rofecoxib and Retinopathy of Prematurity
| Article | Year |
|---|---|
COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, A | 2003 |